{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:20Z","timestamp":1787027780843,"version":"build-2736575974"},"reference-count":51,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA\/POR\/2014\/545"],"award-info":[{"award-number":["HRA\/POR\/2014\/545"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen Breast Cancer Foundation","doi-asserted-by":"publisher","award":["DSLRF pilot"],"award-info":[{"award-number":["DSLRF pilot"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["13\/IA\/1994 (AH)"],"award-info":[{"award-number":["13\/IA\/1994 (AH)"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RI\/3737 (MD)"],"award-info":[{"award-number":["16\/RI\/3737 (MD)"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfeicoamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Process 013306\/2013-08 (RGBC)"],"award-info":[{"award-number":["Process 013306\/2013-08 (RGBC)"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Breast Cancer Ireland","award":["(AH)"],"award-info":[{"award-number":["(AH)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Breast ductal carcinoma in situ (DCIS) is clinically challenging, featuring high diagnosis rates and few targeted therapies. Expression\/signaling from junctional adhesion molecule-A (JAM-A) has been linked to poor prognosis in invasive breast cancers, but its role in DCIS is unknown. Since progression from DCIS to invasive cancer has been linked with overexpression of the human epidermal growth factor receptor-2 (HER2), and JAM-A regulates HER2 expression, we evaluated JAM-A as a therapeutic target in DCIS. JAM-A expression was immunohistochemically assessed in patient DCIS tissues. A novel JAM-A antagonist (JBS2) was designed and tested alone\/in combination with the HER2 kinase inhibitor lapatinib, using SUM-225 cells in vitro and in vivo as validated DCIS models. Murine tumors were proteomically analyzed. JAM-A expression was moderate\/high in 96% of DCIS patient tissues, versus 23% of normal adjacent tissues. JBS2 bound to recombinant JAM-A, inhibiting cell viability in SUM-225 cells and a primary DCIS culture in vitro and in a chick embryo xenograft model. JBS2 reduced tumor progression in in vivo models of SUM-225 cells engrafted into mammary fat pads or directly injected into the mammary ducts of NOD-SCID mice. Preliminary proteomic analysis revealed alterations in angiogenic and apoptotic pathways. High JAM-A expression in aggressive DCIS lesions and their sensitivity to treatment by a novel JAM-A antagonist support the viability of testing JAM-A as a novel therapeutic target in DCIS.<\/jats:p>","DOI":"10.3390\/cancers14051303","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T09:24:53Z","timestamp":1646299493000},"page":"1303","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression"],"prefix":"10.3390","volume":"14","author":[{"given":"Yvonne E.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-2427","authenticated-orcid":false,"given":"Guannan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara L.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Madden","sequence":"additional","affiliation":[{"name":"Data Science Centre, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"MacEneaney","sequence":"additional","affiliation":[{"name":"Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo G. B.","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-8017","authenticated-orcid":false,"given":"Cathy E.","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6944-154X","authenticated-orcid":false,"given":"Hanne","family":"Jahns","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University College Dublin, Dublin 4, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Brennan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-6246","authenticated-orcid":false,"given":"Mattia","family":"Cremona","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-3610","authenticated-orcid":false,"given":"Katherine","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Casucci","sequence":"additional","affiliation":[{"name":"School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-4598","authenticated-orcid":false,"given":"Faizah A.","family":"Sani","sequence":"additional","affiliation":[{"name":"School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Fay","sequence":"additional","affiliation":[{"name":"Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri H.","family":"Vellanki","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-9408","authenticated-orcid":false,"given":"Siobhan","family":"O\u2019Flaherty","sequence":"additional","affiliation":[{"name":"Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-1306","authenticated-orcid":false,"given":"Marc","family":"Devocelle","sequence":"additional","affiliation":[{"name":"Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9617-7983","authenticated-orcid":false,"given":"Arnold D. K.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3520-6394","authenticated-orcid":false,"given":"Kieran","family":"Brennan","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5656-6703","authenticated-orcid":false,"given":"Saraswati","family":"Sukumar","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-6584","authenticated-orcid":false,"given":"Ann M.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Surgery, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10911-018-9415-1","article-title":"Current Therapeutic Approaches to DCIS","volume":"23","author":"Doke","year":"2018","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"Ma","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/modpathol.2014.141","article-title":"Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up","volume":"28","author":"Sanders","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/onc.2009.341","article-title":"Serum protein signature may improve detection of ductal carcinoma in situ of the breast","volume":"29","author":"Solassol","year":"2010","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1152\/physrev.00004.2017","article-title":"Junctional Adhesion Molecules (JAMs): Cell Adhesion Receptors With Pleiotropic Functions in Cell Physiology and Development","volume":"97","author":"Ebnet","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/onc.2012.276","article-title":"Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling","volume":"32","author":"Brennan","year":"2013","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ijc.27772","article-title":"A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody","volume":"132","author":"Goetsch","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13058-018-1064-1","article-title":"Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings","volume":"20","author":"Leech","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ijc.24498","article-title":"JAM-A expression positively correlates with poor prognosis in breast cancer patients","volume":"125","author":"McSherry","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Murakami, M., Giampietro, C., Giannotta, M., Corada, M., Torselli, I., Orsenigo, F., Cocito, A., d\u2019Ario, G., Mazzarol, G., and Confalonieri, S. (2011). Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021242"},{"key":"ref_13","first-page":"79","article-title":"The F11 Receptor (F11R)\/Junctional Adhesion Molecule-A (JAM-A) (F11R\/JAM-A) in cancer progression","volume":"477","author":"Babinska","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_14","first-page":"1066","article-title":"Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma","volume":"13","author":"Liu","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/carcin\/bgz084","article-title":"Intraductal fulvestrant for therapy of ERalpha-positive ductal carcinoma in situ of the breast: A preclinical study","volume":"40","author":"Wang","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1093\/emboj\/20.16.4391","article-title":"X-ray structure of junctional adhesion molecule: Structural basis for homophilic adhesion via a novel dimerization motif","volume":"20","author":"Kostrewa","year":"2001","journal-title":"EMBO J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1073\/pnas.0937718100","article-title":"Crystal structure of human junctional adhesion molecule 1: Implications for reovirus binding","volume":"100","author":"Prota","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1091\/mbc.e14-01-0018","article-title":"Trans-dimerization of JAM-A regulates Rap2 and is mediated by a domain that is distinct from the cis-dimerization interface","volume":"25","author":"Monteiro","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"33306","DOI":"10.18632\/oncotarget.8949","article-title":"Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer","volume":"7","author":"Yoshida","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-9966-30-45","article-title":"An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models","volume":"30","author":"Donatello","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Aslan, O., Cremona, M., Morgan, C., Cheung, L.W., Mills, G.B., and Hennessy, B.T. (2018). Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4035-0"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-5956-10-56","article-title":"An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays","volume":"10","author":"Guo","year":"2012","journal-title":"Proteome Sci."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Assarsson, E., Lundberg, M., Holmquist, G., Bjorkesten, J., Thorsen, S.B., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., and Edfeldt, G. (2014). Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095192"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1091\/mbc.e07-09-0869","article-title":"Cis-dimerization Mediates Function of Junctional Adhesion Molecule A","volume":"19","author":"Severson","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2018.09.032","article-title":"Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth","volume":"440\u2013441","author":"Vellanki","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1242\/jcs.02771","article-title":"Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific","volume":"119","author":"Naik","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_28","first-page":"921","article-title":"Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, -4, -7, occludin and JAM-A, in human cervical adenocarcinoma","volume":"31","author":"Akimoto","year":"2016","journal-title":"Histol. Histopathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/cas.13385","article-title":"Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma","volume":"108","author":"Magara","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.MP.0000038462.62634.B1","article-title":"The role of HER2\/neu overexpression\/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast","volume":"15","author":"Latta","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ddmod.2004.05.001","article-title":"Disease models of breast cancer","volume":"1","author":"Gupta","year":"2004","journal-title":"Drug Discov. Today Dis. Models"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1038\/celldisc.2015.24","article-title":"A novel ER-microtubule-binding protein, ERLIN2, stabilizes Cyclin B1 and regulates cell cycle progression","volume":"1","author":"Zhang","year":"2015","journal-title":"Cell Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/annonc\/mdv062","article-title":"Molecular phenotypes of DCIS predict overall and invasive recurrence","volume":"26","author":"Williams","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000355476","article-title":"Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells","volume":"85","author":"Tsukabe","year":"2013","journal-title":"Oncology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-019-05471-x","article-title":"Functional inhibition of F11 receptor (F11R\/junctional adhesion molecule-A\/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment","volume":"179","author":"Bednarek","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr2358","article-title":"An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ","volume":"11","author":"Behbod","year":"2009","journal-title":"Breast Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","article-title":"A Preclinical Model for ERalpha-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response","volume":"29","author":"Sflomos","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106ra108","DOI":"10.1126\/scitranslmed.3002368","article-title":"Preclinical and clinical evaluation of intraductally administered agents in early breast cancer","volume":"3","author":"Stearns","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj3420287","article-title":"Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: Identification of five sites of phosphorylation in vivo","volume":"342","author":"Casamayor","year":"1999","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/bcr3480","article-title":"An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models","volume":"15","author":"Xia","year":"2013","journal-title":"Breast Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1158\/0008-5472.CAN-09-1636","article-title":"Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells","volume":"69","author":"Chen","year":"2009","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1038\/onc.2016.203","article-title":"Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth","volume":"35","author":"Werden","year":"2016","journal-title":"Oncogene"},{"key":"ref_44","first-page":"5876","article-title":"SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target","volume":"14","author":"Ma","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/ijc.28271","article-title":"Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2","volume":"133","author":"Cortes","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.ajpath.2011.08.021","article-title":"The ADAMTS1 protease gene is required for mammary tumor growth and metastasis","volume":"179","author":"Ricciardelli","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1083\/jcb.200409162","article-title":"Raf-1 regulates Rho signaling and cell migration","volume":"168","author":"Ehrenreiter","year":"2005","journal-title":"J. Cell. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr2853","article-title":"Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase","volume":"13","author":"McSherry","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjc.6602567","article-title":"Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ","volume":"92","author":"Wulfing","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jclinpath-2019-206116","article-title":"Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast","volume":"73","author":"Vermeulen","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/onc.2011.297","article-title":"MUC16 induced rapid G2\/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells","volume":"31","author":"Lakshmanan","year":"2012","journal-title":"Oncogene"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/5\/1303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:31:21Z","timestamp":1760135481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/5\/1303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["cancers14051303"],"URL":"https:\/\/doi.org\/10.3390\/cancers14051303","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}